Results 21 to 30 of about 22,552 (237)

Loss of antiphospholipid antibody positivity post-thrombosis in SLE

open access: yesLupus Science and Medicine, 2020
Background/Purpose Loss of positivity of antiphospholipid antibodies has been observed in clinical practice post-thrombosis in patients with SLE with secondary antiphospholipid syndrome (APS). Our study defined the frequency of this loss and the duration
Muznay Khawaja
doaj   +1 more source

Drug-Induced Lupus with Leukocytoclastic Vasculitis Associated with Apixaban

open access: yesCase Reports in Rheumatology, 2021
Drug-induced lupus is an iatrogenic-induced autoimmune disease with common offending agents well documented in the literature. To our knowledge, there are no prior case reports of drug-induced lupus associated with apixaban or any other direct oral ...
John Yang   +3 more
doaj   +1 more source

Osteomyelitis and septic arthritis in neonatal lupus erythematosus patients

open access: yesJournal of Pediatric Surgery Case Reports, 2022
Osteomyelitis in neonates is quite uncommon and often appears without a typical sign. Clinicians' late diagnosis and inappropriate treatment may result in severe sequelae. We report a rare case of osteomyelitis and septic arthritis infant with a mother's
Virany Diana   +4 more
doaj   +1 more source

The Lupus Anticoagulant paradox [PDF]

open access: yes, 2021
Department of Biochemistry and clinical biochemistry, Nicolae Testemitanu SUMPhIntroduction: Purpose: The goal of the research is to present the reasons that cause the respective prolongation of the coagulation time induced by LA to be mostly ...
Cimpoi, Aurelia, Prichici, Victoria
core  

Hepatic venous outflow block in a young patient with Systemic Lupus Erythematosus [PDF]

open access: yesJournal of Analytical Research in Clinical Medicine, 2015
Introduction: Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a 3 years survival rate of 50%. Several conditions have been implicated as a cause of Budd-Chiari syndrome, including myeloproliferative disorders ...
Ali Ghavidel
doaj   +1 more source

A SYSTEMATIC LITERATURE REVIEW OF BUDD-CHIARI SYNDROME IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

open access: yesHematology, Transfusion and Cell Therapy, 2021
Objective: Antiphospholipid syndrome is associated with multiple and recurrent episodes of arterial and venous thrombosis, thrombocytopenia, spontaneous fetal losses, and high levels of antiphospholipid antibodies. These antibodies can also be present in
TL Correa   +3 more
doaj   +1 more source

Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH

open access: yes, 2016
No abstract ...
COSMI, BENILDE   +5 more
core   +1 more source

Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention

open access: yesThrombosis Journal, 2021
Background Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is characterized by bleeding and thrombosis in patients with autoimmune diseases or infections.
Atsushi Sakamoto   +9 more
doaj   +1 more source

Lupus Anticoagulant, Von Willerbrand Factor and Interleukin-6 as a reliable predictor of the need for mechanical ventilation in Covid-19

open access: yesGalicia Clínica
Background: Coronavirus disease 2019 is characterized by causing thromboembolic events due to a procoagulant state. The possible relationship between lupus anticoagulant and patient's procoagulant state is controversial and no study has specifically ...
Ana Latorre Díez   +7 more
doaj   +1 more source

Clinical significance of antibodies to the phosphatidylserine/prothrombin complex

open access: yesСовременная ревматология, 2022
Classical serological markers of antiphospholipid syndrome (APS) are antibodies to cardiolipin, antibodies to β2-glycoprotein 1, and lupus anticoagulant.
T. M. Reshetnyak   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy